Mark T. Wagner serves as Executive at Alliqua BioMedical, Inc., where they oversee executive responsibilities. Since joining the company, Mark T. Wagner has executed 6 insider transactions totaling $48.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 28, 2021 involved exercising options for 3,334 shares valued at $0.
Mark T. Wagner currently holds 3,334 shares of Alliqua BioMedical, Inc. (ALQA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark T. Wagner has been a net buyer of ALQA stock. They have purchased $48.0K and sold $0 worth of shares.
Mark T. Wagner's most recent insider trade was on Jun 28, 2021, when they sold 3,334 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.40 |
| Discretionary |
| Mar 21, 2017 | ALQA | $50.8K | Other | 75,876 | $0.67 | Discretionary |
| Mar 16, 2016 | ALQA | $192.9K | Other | 73,893 | $2.61 | Discretionary |
| Nov 6, 2015 | ALQA | $23.0K | Purchase | 8,000 | $2.88 | Discretionary |
| May 29, 2015 | ALQA | $0 | Award | 174,033 | $N/A | Discretionary |